tert-Butyl (3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 98%, 1g

7-Bromo-2-methylimidazo[1,2-a]pyridin-3-amine, 97%, 250mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95.0%, 250mg

2-(2-Pyridylamino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 10g

2-(PIPERIDIN-1-YL)-6-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 5g

1-AMINO-4,4-DIFLUOROCYCLOHEXANE-1-CARBOXYLIC ACID, 95.0%, 100g

5-Bromo-benzo[b]thiophene-2-carbaldehyde, 95.0%, 250mg

1-Chloro-4,5-dimethyl-2-nitrobenzene, 95.0%, 5g

2-(2,5-Difluorophenyl)-2-oxoacetic acid, 95%, 5g

4-Fluorophenylhydrazine hydrochloride, 97.0%, 500g

Ethyl 2,6-dimethoxypyridine-3-carboxylate, 97%, 1g

PMPip BTA, 100 g, >=99%, emballage en verre

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 5g